Wednesday, April 3, 2013

Tecfidera (BG12) Approved by FDA for Relapsing MS

The long anticipated oral MS drug known as BG12 has been approved by the FDA for use in relapsing forms of multiple sclerosis.  The new drug will be sold by Biogen Idec under the brand name Tecfidera (dimethyl fumarate).

Tec-fi-dera is an oral drug which is taken twice daily with or without food.  Take Tecfidera exactly as your doctor instructs you to take it.  Biogen states that the recommended starting dose is one 120mg capsule taken by mouth 2 times a day for 7 days.  The recommended dose after 7 days is one 240 mg capsule taken by mouth 2 times a day.  Swallow Tecfidera whole, without crushing, crewing, or sprinkling capsule contents on food.

What are the possible side effects of Tecfidera?

Read this post in its entirety:
Tecfidera (BG12), A New Oral Medication for Relapsing Forms of MS

No comments:

Post a Comment